Inbiotech Ltd. is a pharmaceutical company dedicated at providing high-quality healthcare by developing, manufacturing, and marketing affordable generic, branded generic, and Over-the Counter (OTC) pharmaceuticals. Headquartered in Sofia, the company has a successful track record in obtaining first-to-market approvals in Bulgaria for generic drugs in the cardiovascular, gastroenterology, and psychiatry therapeutic areas. The company employs a team of leading professionals with long-standing experience and proven expertise in the pharmaceutical industry. Inbiotech has a growing product portfolio which covers a variety of therapeutic areas, including proven medecines for the treatment of diseases such as hypertension, hyperlipidemia, ulcer disease of the stomach and duodenum, skeleton-muscular diseases, as well as a number of depressive diseases. Leading principles in our drug policy and strategy are the comprehensive research and analysis of the therapeutical and socio-economic effects of the project, combined with targeted marketing and management efforts to complete the cycle from science to successful market realization.
Looking for a particular Inbiotech employee's phone or email?
The Inbiotech annual revenue was $5 million in 2026.
Inna Kirkova is the CEO of Inbiotech.
4 people are employed at Inbiotech.
Inbiotech is based in Sofia, Sofia-Capital.
The NAICS codes for Inbiotech are [325, 32541, 3254, 32].
The SIC codes for Inbiotech are [2834, 28, 283].